Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors

Patient-derived xenograft (PDX) models are used as powerful tools for understanding cancer biology in PDX clinical trials and co-clinical trials. In this systematic review, we focus on PDX clinical trials or co-clinical trials for drug development in solid tumors and summarize the utility of PDX mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Koga, Yoshikatsu, Ochiai, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562882/
https://www.ncbi.nlm.nih.gov/pubmed/31064068
http://dx.doi.org/10.3390/cells8050418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562882/
https://www.ncbi.nlm.nih.gov/pubmed/31064068
http://dx.doi.org/10.3390/cells8050418

Ejemplares similares